MedPath

Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study

Not Applicable
Conditions
Weight Loss
Roux-en-Y Gastric Bypass
Cancer
Mendelian Randomization
Registration Number
JPRN-UMIN000052206
Lead Sponsor
Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

GWAS datasets containing populations of different ancestries

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The impact of weight loss after RYGB on cancer risk
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath